KYMERA THERAPEUTICS, INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-61.2% -$5M
$3M
Cost of Revenue↓-61.2% -$5M
$3M
R&D↑+16.7% +$12M
$84M
D&A↑+2.3% +$45K
$2M
Operating Income↓-28.3% -$20M
$-93M
EBITDA↑+2.3% +$45K
$2M
Tax Provision
—
Net Income↓-31.5% -$20M
$-82M
Operating Margin↓-1419.4pts
-3347.4%
Net Margin↓-1302.7pts
-2973.0%
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-7.9pts
0.0%
Operating Lease Cost↓-1.7% -$42K
$2M
Revenue YoY Variation↑+23.4pts
-61.2%
Income YoY Variation↓-2.9pts
-28.3%
Revenue QoQ Variation↓-93.8pts
3.8%
Income QoQ Variation↑+32.2pts
-9.4%